Loading...
CYP51 as drug targets for fungi and protozoan parasites: past, present and future
The efficiency of treatment of human infections with the unicellular eukaryotic pathogens such as fungi and protozoa remains deeply unsatisfactory. For example, the mortality rates from nosocomial fungemia in critically ill, immunosuppressed or post cancer patients often exceed 50%. A set of six sys...
Na minha lista:
| Udgivet i: | Parasitology |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6185833/ https://ncbi.nlm.nih.gov/pubmed/29642960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0031182018000562 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|